{
    "info": {
        "nct_id": "NCT03480971",
        "official_title": "A Double Blind, Placebo Controlled Dose Range Finding Study to Assess the Safety, Pharmacokinetics, and Efficacy of Tempol for the Reduction of Severe Mucositis in Head and Neck Cancer Patients Undergoing Combined Radio- and Chemotherapy",
        "inclusion_criteria": "1. Be ≥18 years of age with medically diagnosed squamous cell cancer of the head and neck (SCCHN);\n2. Be scheduled to receive radiotherapy or proton therapy administered with a curative intent;\n3. If female and of child bearing potential, be using an effective birth-control method with a history of reliability for the individual participant;\n4. If male and of child bearing potential, adequate methods of contraception must be employed including use of condoms with spermicide. No sperm donation for 90 days until after the conclusion of the study;\n5. Must be receiving cisplatin for chemotherapy;\n6. Be properly informed of the nature and risks of the clinical investigation, comply with all clinical investigation-related procedures, and sign an Informed Consent Form prior to entering the clinical investigation;\n7. Must have a score 2 or less on the ECOG performance status;\n8. Participant life expectancy ≥ 6 months; and\n9. Adequate baseline organ function (hematologic, liver, renal, nutritional and metabolic):\n\nHaematology:\n\nAbsolute neutrophil count (ANC) ≥1.5 Hemoglobin ≥ 10 g/dL Platelets ≥ 100,000 per microliter of blood\n\nHepatic:\n\nTotal bilirubin ≤ 2 X (Upper limit normal) ULN Alanine amino transferase (ALT) and Aspartate aminotransferase (AST) ≤5 x ULN\n\nRenal:\n\nSerum creatinine ≤ ULN or, if > ULN calculated creatinine clearance (CrCl) ≥ 60 mL/min.\n\nNutritional and metabolic:\n\nUrine Albumin < 3.0 mg/dl\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Prior radiotherapy of the head and neck;\n2. Have a clinically significant infection defined as any acute viral, bacterial or fungal infection, which requires specific therapy. Anti-infectious therapy must have been completed within 14 days of starting study treatment;\n3. Be taking any non-approved therapy for oral mucositis, including β-carotene, tocopherol, laser irradiation, brushing the oral mucosa with silver-nitrate prophylactically, systemic TGF-β (transforming growth factor beta), or systemic KGF (keratinocyte growth factor) during or within 14 days of starting treatment;\n4. Be taking mugard;\n5. Be taking prostaglandins, pentoxifylline or leucovorin during or within 14 days of starting treatment;\n6. Be rinsing with allopurinol, hydrogen peroxide, sucralfate, or chlorhexidine mouthwashes during or within 14 days of starting treatment;\n7. Have had a recent, serious, non-malignant medical complication that, in the opinion of the investigator, makes the individual unsuitable for study participation;\n8. Have used an investigational drug within 28 days of the initiation of study treatment;\n9. Have a history of a positive blood test for HIV;\n10. At the time of screening, having a significant active medical illness which, in the opinion of the investigator, would preclude completion of the study;\n11. Participants with a treatment plan consisting of chemoradiation followed by further chemotherapy;\n12. Participants with body weight less than 35 kg, 77 lbs;\n13. Women who are pregnant or who are breastfeeding;\n14. Participants with known intolerance to platin drugs;\n15. History of insulin-dependent Diabetes Mellitus; and\n16. Participants with Hepatitis B/C.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "7. Must have a score 2 or less on the ECOG performance status;",
            "criterions": [
                {
                    "exact_snippets": "score 2 or less on the ECOG performance status",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Nutritional and metabolic:",
            "criterions": [
                {
                    "exact_snippets": "Nutritional and metabolic:",
                    "criterion": "nutritional status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Nutritional and metabolic:",
                    "criterion": "metabolic status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Serum creatinine ≤ ULN or, if > ULN calculated creatinine clearance (CrCl) ≥ 60 mL/min.",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine ≤ ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1,
                                "unit": "ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "> ULN calculated creatinine clearance (CrCl) ≥ 60 mL/min",
                    "criterion": "calculated creatinine clearance (CrCl)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 60,
                                "unit": "mL/min"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Absolute neutrophil count (ANC) ≥1.5 Hemoglobin ≥ 10 g/dL Platelets ≥ 100,000 per microliter of blood",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count (ANC) ≥1.5",
                    "criterion": "absolute neutrophil count (ANC)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1.5,
                                "unit": "10^9/L or K/uL (unit not specified in snippet)"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Hemoglobin ≥ 10 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "g/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Platelets ≥ 100,000 per microliter of blood",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100000,
                                "unit": "per microliter"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Renal:",
            "criterions": [
                {
                    "exact_snippets": "Renal:",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "criterion not specified"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Must be receiving cisplatin for chemotherapy;",
            "criterions": [
                {
                    "exact_snippets": "Must be receiving cisplatin for chemotherapy",
                    "criterion": "cisplatin chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "receiving",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Be properly informed of the nature and risks of the clinical investigation, comply with all clinical investigation-related procedures, and sign an Informed Consent Form prior to entering the clinical investigation;",
            "criterions": [
                {
                    "exact_snippets": "Be properly informed of the nature and risks of the clinical investigation",
                    "criterion": "patient information about clinical investigation",
                    "requirements": [
                        {
                            "requirement_type": "informed status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "comply with all clinical investigation-related procedures",
                    "criterion": "compliance with clinical investigation procedures",
                    "requirements": [
                        {
                            "requirement_type": "compliance",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "sign an Informed Consent Form prior to entering the clinical investigation",
                    "criterion": "signed Informed Consent Form",
                    "requirements": [
                        {
                            "requirement_type": "signed",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to entering the clinical investigation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Hepatic:",
            "criterions": [
                {
                    "exact_snippets": "Hepatic:",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "criterion not specified"
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Be scheduled to receive radiotherapy or proton therapy administered with a curative intent;",
            "criterions": [
                {
                    "exact_snippets": "scheduled to receive radiotherapy or proton therapy",
                    "criterion": "planned therapy",
                    "requirements": [
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "radiotherapy",
                                "proton therapy"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "administered with a curative intent",
                    "criterion": "treatment intent",
                    "requirements": [
                        {
                            "requirement_type": "intent",
                            "expected_value": "curative"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. If male and of child bearing potential, adequate methods of contraception must be employed including use of condoms with spermicide. No sperm donation for 90 days until after the conclusion of the study;",
            "criterions": [
                {
                    "exact_snippets": "If male and of child bearing potential, adequate methods of contraception must be employed including use of condoms with spermicide.",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "usage",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "condoms with spermicide"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "No sperm donation for 90 days until after the conclusion of the study;",
                    "criterion": "sperm donation",
                    "requirements": [
                        {
                            "requirement_type": "prohibition_duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 90,
                                "unit": "days after the conclusion of the study"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Total bilirubin ≤ 2 X (Upper limit normal) ULN Alanine amino transferase (ALT) and Aspartate aminotransferase (AST) ≤5 x ULN",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin ≤ 2 X (Upper limit normal) ULN",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Alanine amino transferase (ALT) ... ≤5 x ULN",
                    "criterion": "alanine aminotransferase (ALT)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Aspartate aminotransferase (AST) ≤5 x ULN",
                    "criterion": "aspartate aminotransferase (AST)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "x ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. If female and of child bearing potential, be using an effective birth-control method with a history of reliability for the individual participant;",
            "criterions": [
                {
                    "exact_snippets": "If female and of child bearing potential",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "female"
                        }
                    ]
                },
                {
                    "exact_snippets": "If female and of child bearing potential",
                    "criterion": "child bearing potential",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "be using an effective birth-control method",
                    "criterion": "birth-control method use",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "effectiveness",
                            "expected_value": "effective"
                        }
                    ]
                },
                {
                    "exact_snippets": "with a history of reliability for the individual participant",
                    "criterion": "birth-control method reliability",
                    "requirements": [
                        {
                            "requirement_type": "history of reliability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Adequate baseline organ function (hematologic, liver, renal, nutritional and metabolic):",
            "criterions": [
                {
                    "exact_snippets": "Adequate baseline organ function (hematologic",
                    "criterion": "hematologic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate baseline organ function ... liver",
                    "criterion": "liver function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate baseline organ function ... renal",
                    "criterion": "renal function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate baseline organ function ... nutritional",
                    "criterion": "nutritional status",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Adequate baseline organ function ... metabolic",
                    "criterion": "metabolic function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Haematology:",
            "criterions": [
                {
                    "exact_snippets": "Haematology:",
                    "criterion": "haematology",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "criterion heading only; no specific requirement given"
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Be ≥18 years of age with medically diagnosed squamous cell cancer of the head and neck (SCCHN);",
            "criterions": [
                {
                    "exact_snippets": "Be ≥18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "medically diagnosed squamous cell cancer of the head and neck (SCCHN)",
                    "criterion": "squamous cell cancer of the head and neck (SCCHN)",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Urine Albumin < 3.0 mg/dl",
            "criterions": [
                {
                    "exact_snippets": "Urine Albumin < 3.0 mg/dl",
                    "criterion": "urine albumin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3.0,
                                "unit": "mg/dl"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Participant life expectancy ≥ 6 months; and",
            "criterions": [
                {
                    "exact_snippets": "Participant life expectancy ≥ 6 months",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "8. Have used an investigational drug within 28 days of the initiation of study treatment;",
            "criterions": [
                {
                    "exact_snippets": "Have used an investigational drug within 28 days of the initiation of study treatment",
                    "criterion": "investigational drug use",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": {
                                "operator": "<=",
                                "value": 28,
                                "unit": "days"
                            }
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Prior radiotherapy of the head and neck;",
            "criterions": [
                {
                    "exact_snippets": "Prior radiotherapy of the head and neck",
                    "criterion": "radiotherapy to the head and neck",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Have a history of a positive blood test for HIV;",
            "criterions": [
                {
                    "exact_snippets": "history of a positive blood test for HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "history of positive blood test",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "12. Participants with body weight less than 35 kg, 77 lbs;",
            "criterions": [
                {
                    "exact_snippets": "body weight less than 35 kg, 77 lbs",
                    "criterion": "body weight",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 35,
                                "unit": "kg"
                            }
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 77,
                                "unit": "lbs"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Be rinsing with allopurinol, hydrogen peroxide, sucralfate, or chlorhexidine mouthwashes during or within 14 days of starting treatment;",
            "criterions": [
                {
                    "exact_snippets": "Be rinsing with allopurinol ... mouthwashes during or within 14 days of starting treatment",
                    "criterion": "use of allopurinol mouthwash",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Be rinsing with ... hydrogen peroxide ... mouthwashes during or within 14 days of starting treatment",
                    "criterion": "use of hydrogen peroxide mouthwash",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Be rinsing with ... sucralfate ... mouthwashes during or within 14 days of starting treatment",
                    "criterion": "use of sucralfate mouthwash",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Be rinsing with ... chlorhexidine mouthwashes during or within 14 days of starting treatment",
                    "criterion": "use of chlorhexidine mouthwash",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Be taking any non-approved therapy for oral mucositis, including β-carotene, tocopherol, laser irradiation, brushing the oral mucosa with silver-nitrate prophylactically, systemic TGF-β (transforming growth factor beta), or systemic KGF (keratinocyte growth factor) during or within 14 days of starting treatment;",
            "criterions": [
                {
                    "exact_snippets": "Be taking any non-approved therapy for oral mucositis, including β-carotene, tocopherol, laser irradiation, brushing the oral mucosa with silver-nitrate prophylactically, systemic TGF-β (transforming growth factor beta), or systemic KGF (keratinocyte growth factor) during or within 14 days of starting treatment",
                    "criterion": "non-approved therapy for oral mucositis",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 14,
                                        "unit": "days"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "14. Participants with known intolerance to platin drugs;",
            "criterions": [
                {
                    "exact_snippets": "Participants with known intolerance to platin drugs",
                    "criterion": "intolerance to platin drugs",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Be taking mugard;",
            "criterions": [
                {
                    "exact_snippets": "Be taking mugard;",
                    "criterion": "mugard use",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Have a clinically significant infection defined as any acute viral, bacterial or fungal infection, which requires specific therapy. Anti-infectious therapy must have been completed within 14 days of starting study treatment;",
            "criterions": [
                {
                    "exact_snippets": "clinically significant infection defined as any acute viral, bacterial or fungal infection, which requires specific therapy",
                    "criterion": "clinically significant infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "acute viral",
                                "bacterial",
                                "fungal"
                            ]
                        },
                        {
                            "requirement_type": "requires specific therapy",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Anti-infectious therapy must have been completed within 14 days of starting study treatment",
                    "criterion": "anti-infectious therapy",
                    "requirements": [
                        {
                            "requirement_type": "completion time before study treatment",
                            "expected_value": {
                                "operator": "<=",
                                "value": 14,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "13. Women who are pregnant or who are breastfeeding;",
            "criterions": [
                {
                    "exact_snippets": "Women who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnant",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "who are breastfeeding",
                    "criterion": "breastfeeding status",
                    "requirements": [
                        {
                            "requirement_type": "breastfeeding",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "15. History of insulin-dependent Diabetes Mellitus; and",
            "criterions": [
                {
                    "exact_snippets": "History of insulin-dependent Diabetes Mellitus",
                    "criterion": "insulin-dependent Diabetes Mellitus",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Have had a recent, serious, non-malignant medical complication that, in the opinion of the investigator, makes the individual unsuitable for study participation;",
            "criterions": [
                {
                    "exact_snippets": "recent, serious, non-malignant medical complication",
                    "criterion": "non-malignant medical complication",
                    "requirements": [
                        {
                            "requirement_type": "recency",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "severity",
                            "expected_value": "serious"
                        }
                    ]
                },
                {
                    "exact_snippets": "in the opinion of the investigator, makes the individual unsuitable for study participation",
                    "criterion": "suitability for study participation (per investigator judgment)",
                    "requirements": [
                        {
                            "requirement_type": "investigator judgment",
                            "expected_value": "unsuitable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. At the time of screening, having a significant active medical illness which, in the opinion of the investigator, would preclude completion of the study;",
            "criterions": [
                {
                    "exact_snippets": "having a significant active medical illness",
                    "criterion": "significant active medical illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "which, in the opinion of the investigator, would preclude completion of the study",
                    "criterion": "ability to complete the study",
                    "requirements": [
                        {
                            "requirement_type": "investigator opinion of ability to complete study",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "16. Participants with Hepatitis B/C.",
            "criterions": [
                {
                    "exact_snippets": "Participants with Hepatitis B/C.",
                    "criterion": "Hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants with Hepatitis B/C.",
                    "criterion": "Hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "11. Participants with a treatment plan consisting of chemoradiation followed by further chemotherapy;",
            "criterions": [
                {
                    "exact_snippets": "treatment plan consisting of chemoradiation followed by further chemotherapy",
                    "criterion": "treatment plan",
                    "requirements": [
                        {
                            "requirement_type": "components",
                            "expected_value": [
                                "chemoradiation",
                                "further chemotherapy"
                            ]
                        },
                        {
                            "requirement_type": "sequence",
                            "expected_value": "chemoradiation followed by further chemotherapy"
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Be taking prostaglandins, pentoxifylline or leucovorin during or within 14 days of starting treatment;",
            "criterions": [
                {
                    "exact_snippets": "Be taking prostaglandins ... during or within 14 days of starting treatment",
                    "criterion": "prostaglandin use",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Be taking ... pentoxifylline ... during or within 14 days of starting treatment",
                    "criterion": "pentoxifylline use",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Be taking ... leucovorin during or within 14 days of starting treatment",
                    "criterion": "leucovorin use",
                    "requirements": [
                        {
                            "requirement_type": "use during or within 14 days of starting treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}